ID   CAHM1_HUMAN             Reviewed;         346 AA.
AC   Q8IU99; Q5W091;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 2.
DT   07-APR-2021, entry version 140.
DE   RecName: Full=Calcium homeostasis modulator protein 1;
DE   AltName: Full=Protein FAM26C;
GN   Name=CALHM1 {ECO:0000312|HGNC:HGNC:23494}; Synonyms=FAM26C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-86.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, GLYCOSYLATION
RP   AT ASN-140, VARIANT PRO-86, POLYMORPHISM, AND MUTAGENESIS OF ASN-72; ASN-74
RP   AND ASN-140.
RX   PubMed=18585350; DOI=10.1016/j.cell.2008.05.048;
RA   Dreses-Werringloer U., Lambert J.-C., Vingtdeux V., Zhao H., Vais H.,
RA   Siebert A., Jain A., Koppel J., Rovelet-Lecrux A., Hannequin D.,
RA   Pasquier F., Galimberti D., Scarpini E., Mann D., Lendon C., Campion D.,
RA   Amouyel P., Davies P., Foskett J.K., Campagne F., Marambaud P.;
RT   "A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and
RT   Alzheimer's disease risk.";
RL   Cell 133:1149-1161(2008).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=19997627; DOI=10.1371/journal.pone.0007682;
RA   Moyer B.D., Hevezi P., Gao N., Lu M., Kalabat D., Soto H., Echeverri F.,
RA   Laita B., Yeh S.A., Zoller M., Zlotnik A.;
RT   "Expression of genes encoding multi-transmembrane proteins in specific
RT   primate taste cell populations.";
RL   PLoS ONE 4:E7682-E7682(2009).
RN   [5]
RP   FUNCTION.
RX   PubMed=21574960; DOI=10.1042/bj20110479;
RA   Gallego-Sandin S., Alonso M.T., Garcia-Sancho J.;
RT   "Calcium homoeostasis modulator 1 (CALHM1) reduces the calcium content of
RT   the endoplasmic reticulum (ER) and triggers ER stress.";
RL   Biochem. J. 437:469-475(2011).
RN   [6]
RP   FUNCTION, ACTIVITY REGULATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ASN-72; ASP-121; GLU-163 AND ASP-166.
RX   PubMed=22711817; DOI=10.1073/pnas.1204023109;
RA   Ma Z., Siebert A.P., Cheung K.H., Lee R.J., Johnson B., Cohen A.S.,
RA   Vingtdeux V., Marambaud P., Foskett J.K.;
RT   "Calcium homeostasis modulator 1 (CALHM1) is the pore-forming subunit of an
RT   ion channel that mediates extracellular Ca2+ regulation of neuronal
RT   excitability.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:E1963-E1971(2012).
RN   [7]
RP   FUNCTION, SUBUNIT, TOPOLOGY, AND SUBCELLULAR LOCATION.
RX   PubMed=23300080; DOI=10.1074/jbc.m112.409789;
RA   Siebert A.P., Ma Z., Grevet J.D., Demuro A., Parker I., Foskett J.K.;
RT   "Structural and functional similarities of calcium homeostasis modulator 1
RT   (CALHM1) ion channel with connexins, pannexins, and innexins.";
RL   J. Biol. Chem. 288:6140-6153(2013).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF TRP-114 AND ASN-140.
RX   PubMed=23345406; DOI=10.1242/jcs.117135;
RA   Dreses-Werringloer U., Vingtdeux V., Zhao H., Chandakkar P., Davies P.,
RA   Marambaud P.;
RT   "CALHM1 controls Ca2+-dependent MEK/ERK/RSK/MSK signaling in neurons.";
RL   J. Cell Sci. 126:1199-1206(2013).
RN   [9]
RP   VARIANT PRO-86.
RX   PubMed=19472444; DOI=10.1111/j.1469-1809.2009.00509.x;
RA   Beecham G.W., Schnetz-Boutaud N., Haines J.L., Pericak-Vance M.A.;
RT   "CALHM1 polymorphism is not associated with late-onset Alzheimer disease.";
RL   Ann. Hum. Genet. 73:379-381(2009).
RN   [10]
RP   VARIANT PRO-86.
RX   PubMed=19070563; DOI=10.1016/j.cell.2008.11.030;
RA   Bertram L., Schjeide B.M., Hooli B., Mullin K., Hiltunen M., Soininen H.,
RA   Ingelsson M., Lannfelt L., Blacker D., Tanzi R.E.;
RT   "No association between CALHM1 and Alzheimer's disease risk.";
RL   Cell 135:993-994(2008).
RN   [11]
RP   VARIANT PRO-86.
RX   PubMed=19191331; DOI=10.1002/humu.20989;
RA   Minster R.L., Demirci F.Y., DeKosky S.T., Kamboh M.I.;
RT   "No association between CALHM1 variation and risk of Alzheimer disease.";
RL   Hum. Mutat. 30:E566-E569(2009).
RN   [12]
RP   VARIANT PRO-86.
RX   PubMed=19191332; DOI=10.1002/humu.20990;
RA   Sleegers K., Brouwers N., Bettens K., Engelborghs S., van Miegroet H.,
RA   De Deyn P.P., Van Broeckhoven C.;
RT   "No association between CALHM1 and risk for Alzheimer dementia in a Belgian
RT   population.";
RL   Hum. Mutat. 30:E570-E574(2009).
RN   [13]
RP   VARIANT PRO-86.
RX   PubMed=19545933; DOI=10.1016/j.neurobiolaging.2009.05.008;
RA   Tan E.K., Ho P., Cheng S.Y., Yih Y., Li H.H., Fook-Chong S., Lee W.L.,
RA   Zhao Y.;
RT   "CALHM1 variant is not associated with Alzheimer's disease among Asians.";
RL   Neurobiol. Aging 32:546.E11-546.E12(2011).
RN   [14]
RP   VARIANT PRO-86.
RX   PubMed=19655363; DOI=10.1002/ajmg.b.31014;
RA   Inoue K., Tanaka N., Yamashita F., Sawano Y., Asada T., Goto Y.;
RT   "The P86L common allele of CALHM1 does not influence risk for Alzheimer
RT   disease in Japanese cohorts.";
RL   Am. J. Med. Genet. B Neuropsychiatr. Genet. 153:532-535(2010).
RN   [15]
RP   VARIANT PRO-86.
RX   PubMed=20061624; DOI=10.3233/jad-2010-1207;
RA   Cui P.J., Zheng L., Cao L., Wang Y., Deng Y.L., Wang G., Xu W., Tang H.D.,
RA   Ma J.F., Zhang T., Ding J.Q., Cheng Q., Chen S.D.;
RT   "CALHM1 P86L polymorphism is a risk factor for Alzheimer's disease in the
RT   Chinese population.";
RL   J. Alzheimers Dis. 19:31-35(2010).
RN   [16]
RP   VARIANT PRO-86.
RX   PubMed=20164592; DOI=10.3233/jad-2010-1357;
RA   Boada M., Antunez C., Lopez-Arrieta J., Galan J.J., Moron F.J.,
RA   Hernandez I., Marin J., Martinez-Lage P., Alegret M., Carrasco J.M.,
RA   Moreno C., Real L.M., Gonzalez-Perez A., Tarraga L., Ruiz A.;
RT   "CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease
RT   in a recessive model.";
RL   J. Alzheimers Dis. 20:247-251(2010).
RN   [17]
RP   VARIANT PRO-86.
RX   PubMed=20847397; DOI=10.3233/jad-2010-100933;
RA   Lambert J.C., Sleegers K., Gonzalez-Perez A., Ingelsson M., Beecham G.W.,
RA   Hiltunen M., Combarros O., Bullido M.J., Brouwers N., Bettens K., Berr C.,
RA   Pasquier F., Richard F., Dekosky S.T., Hannequin D., Haines J.L.,
RA   Tognoni G., Fievet N., Dartigues J.F., Tzourio C., Engelborghs S.,
RA   Arosio B., Coto E., De Deyn P., Del Zompo M., Mateo I., Boada M.,
RA   Antunez C., Lopez-Arrieta J., Epelbaum J., Schjeide B.M., Frank-Garcia A.,
RA   Giedraitis V., Helisalmi S., Porcellini E., Pilotto A., Forti P., Ferri R.,
RA   Delepine M., Zelenika D., Lathrop M., Scarpini E., Siciliano G.,
RA   Solfrizzi V., Sorbi S., Spalletta G., Ravaglia G., Valdivieso F.,
RA   Vepsalainen S., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B.,
RA   Bossu P., Hanon O., Piccardi P., Annoni G., Mann D., Marambaud P.,
RA   Seripa D., Galimberti D., Tanzi R.E., Bertram L., Lendon C., Lannfelt L.,
RA   Licastro F., Campion D., Pericak-Vance M.A., Soininen H.,
RA   Van Broeckhoven C., Alperovitch A., Ruiz A., Kamboh M.I., Amouyel P.;
RT   "The CALHM1 P86L polymorphism is a genetic modifier of age at onset in
RT   Alzheimer's disease: a meta-analysis study.";
RL   J. Alzheimers Dis. 22:247-255(2010).
RN   [18]
RP   VARIANT PRO-86.
RX   PubMed=21378601; DOI=10.1097/ypg.0b013e3283457bcc;
RA   Feher A., Juhasz A., Rimanoczy A., Pakaski M., Kalman J., Janka Z.;
RT   "No association between CALHM1 polymorphism and Alzheimer's disease risk in
RT   a Hungarian population.";
RL   Psychiatr. Genet. 21:249-252(2011).
CC   -!- FUNCTION: Pore-forming subunit of a voltage-gated ion channel required
CC       for sensory perception of sweet, bitter and umami tastes (By
CC       similarity). Specifically present in type II taste bud cells, where it
CC       plays a central role in sweet, bitter and umami taste perception by
CC       inducing ATP release from the cell, ATP acting as a neurotransmitter to
CC       activate afferent neural gustatory pathways (By similarity). Together
CC       with CALHM3, forms a fast-activating voltage-gated ATP-release channel
CC       in type II taste bud cells (TBCs) (By similarity). Acts both as a
CC       voltage-gated and calcium-activated ion channel: mediates neuronal
CC       excitability in response to changes in extracellular Ca(2+)
CC       concentration (PubMed:22711817, PubMed:23300080). Has poor ion
CC       selectivity and forms a wide pore (around 14 Angstroms) that mediates
CC       permeation of Ca(2+), Na(+) and K(+), as well as permeation of
CC       monovalent anions (PubMed:22711817). Acts as an activator of the ERK1
CC       and ERK2 cascade (PubMed:23345406). Triggers endoplasmic reticulum
CC       stress by reducing the calcium content of the endoplasmic reticulum
CC       (PubMed:21574960). May indirectly control amyloid precursor protein
CC       (APP) proteolysis and aggregated amyloid-beta (Abeta) peptides levels
CC       in a Ca(2+) dependent manner (PubMed:18585350).
CC       {ECO:0000250|UniProtKB:D3Z291, ECO:0000269|PubMed:18585350,
CC       ECO:0000269|PubMed:21574960, ECO:0000269|PubMed:22711817,
CC       ECO:0000269|PubMed:23300080, ECO:0000269|PubMed:23345406}.
CC   -!- ACTIVITY REGULATION: Inhibited by Gd(3+), Ruthenium Red, and Zn(2+) and
CC       partially inhibited by 2-aminoethoxydiphenyl borate.
CC       {ECO:0000269|PubMed:22711817}.
CC   -!- SUBUNIT: Homohexamer. Associates with CALHM3 as a pore-forming subunit
CC       in an hetero-hexameric channel complex (By similarity).
CC       {ECO:0000250|UniProtKB:D3Z291, ECO:0000269|PubMed:18585350,
CC       ECO:0000269|PubMed:23300080}.
CC   -!- INTERACTION:
CC       Q8IU99; P05067: APP; NbExp=3; IntAct=EBI-1790341, EBI-77613;
CC       Q8IU99; Q8IU99: CALHM1; NbExp=3; IntAct=EBI-1790341, EBI-1790341;
CC       Q8IU99; P48730-2: CSNK1D; NbExp=3; IntAct=EBI-1790341, EBI-9087876;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:18585350, ECO:0000269|PubMed:22711817,
CC       ECO:0000269|PubMed:23300080}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:18585350}; Multi-pass membrane protein. Basolateral
CC       cell membrane; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:D3Z291}. Note=Colocalizes with HSPA5 at the
CC       endoplasmic reticulum (PubMed:18585350). Localizes to the basolateral
CC       membrane of epithelial cells including taste cells (By similarity).
CC       {ECO:0000250|UniProtKB:D3Z291, ECO:0000269|PubMed:18585350}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in adult brain. Detected
CC       also in retinoic acid-differentiated SH-SY5Y cells. Specifically
CC       expressed in circumvallate taste bud cells.
CC       {ECO:0000269|PubMed:18585350, ECO:0000269|PubMed:19997627}.
CC   -!- POLYMORPHISM: Leu-86 causes a dysregulation of Ca(2+) homeostasis and
CC       amyloid precursor protein (APP) metabolism and has been suggested to be
CC       a risk factor for the development of Alzheimer disease
CC       (PubMed:18585350, PubMed:20061624, PubMed:20164592). However, this
CC       association with Alzheimer disease could not be confirmed in a number
CC       of studies performed in different populations (PubMed:19472444,
CC       PubMed:19070563, PubMed:19191331, PubMed:19191332, PubMed:19545933,
CC       PubMed:19655363, PubMed:21378601). According to a meta-analysis study,
CC       Leu-86 is likely not a genetic determinant of Alzheimer disease but may
CC       modulate age of onset by interacting with the effect of the APOE*4
CC       allele of the APOE gene (PubMed:20847397).
CC       {ECO:0000269|PubMed:18585350, ECO:0000269|PubMed:19070563,
CC       ECO:0000269|PubMed:19191331, ECO:0000269|PubMed:19191332,
CC       ECO:0000269|PubMed:19472444, ECO:0000269|PubMed:19545933,
CC       ECO:0000269|PubMed:19655363, ECO:0000269|PubMed:20061624,
CC       ECO:0000269|PubMed:20164592, ECO:0000269|PubMed:20847397,
CC       ECO:0000269|PubMed:21378601}.
CC   -!- SIMILARITY: Belongs to the CALHM family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL139339; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036193; AAH36193.1; -; mRNA.
DR   EMBL; BC036208; AAH36208.1; -; mRNA.
DR   CCDS; CCDS7550.1; -.
DR   RefSeq; NP_001001412.3; NM_001001412.3.
DR   SMR; Q8IU99; -.
DR   IntAct; Q8IU99; 3.
DR   STRING; 9606.ENSP00000329926; -.
DR   TCDB; 1.A.84.1.1; the calcium homeostasis modulator ca(2+) channel (calhm-c) family.
DR   GlyGen; Q8IU99; 1 site.
DR   iPTMnet; Q8IU99; -.
DR   PhosphoSitePlus; Q8IU99; -.
DR   BioMuta; CALHM1; -.
DR   DMDM; 68565595; -.
DR   PaxDb; Q8IU99; -.
DR   PRIDE; Q8IU99; -.
DR   ProteomicsDB; 70525; -.
DR   Antibodypedia; 3119; 151 antibodies.
DR   DNASU; 255022; -.
DR   Ensembl; ENST00000329905; ENSP00000329926; ENSG00000185933.
DR   GeneID; 255022; -.
DR   KEGG; hsa:255022; -.
DR   UCSC; uc001kxe.3; human.
DR   CTD; 255022; -.
DR   DisGeNET; 255022; -.
DR   GeneCards; CALHM1; -.
DR   HGNC; HGNC:23494; CALHM1.
DR   HPA; ENSG00000185933; Tissue enhanced (brain, kidney, lymphoid tissue).
DR   MIM; 612234; gene.
DR   neXtProt; NX_Q8IU99; -.
DR   OpenTargets; ENSG00000185933; -.
DR   PharmGKB; PA162380954; -.
DR   VEuPathDB; HostDB:ENSG00000185933.6; -.
DR   eggNOG; ENOG502RCIV; Eukaryota.
DR   GeneTree; ENSGT01000000214602; -.
DR   HOGENOM; CLU_069286_0_0_1; -.
DR   InParanoid; Q8IU99; -.
DR   OMA; RYIKCIS; -.
DR   OrthoDB; 960393at2759; -.
DR   PhylomeDB; Q8IU99; -.
DR   TreeFam; TF329085; -.
DR   PathwayCommons; Q8IU99; -.
DR   BioGRID-ORCS; 255022; 4 hits in 987 CRISPR screens.
DR   GenomeRNAi; 255022; -.
DR   Pharos; Q8IU99; Tbio.
DR   PRO; PR:Q8IU99; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q8IU99; protein.
DR   Bgee; ENSG00000185933; Expressed in prefrontal cortex and 59 other tissues.
DR   Genevisible; Q8IU99; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IDA:UniProtKB.
DR   GO; GO:0005261; F:cation channel activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IEA:Ensembl.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IDA:UniProtKB.
DR   GO; GO:0015867; P:ATP transport; ISS:UniProtKB.
DR   GO; GO:0006812; P:cation transport; IDA:UniProtKB.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0050913; P:sensory perception of bitter taste; ISS:UniProtKB.
DR   GO; GO:0050916; P:sensory perception of sweet taste; ISS:UniProtKB.
DR   GO; GO:0050917; P:sensory perception of umami taste; ISS:UniProtKB.
DR   InterPro; IPR029569; CALHM.
DR   InterPro; IPR029568; CALHM1.
DR   PANTHER; PTHR32261; PTHR32261; 1.
DR   PANTHER; PTHR32261:SF2; PTHR32261:SF2; 1.
DR   Pfam; PF14798; Ca_hom_mod; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Endoplasmic reticulum; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Sensory transduction; Taste; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..346
FT                   /note="Calcium homeostasis modulator protein 1"
FT                   /id="PRO_0000186723"
FT   TOPO_DOM        1..17
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        18..38
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        39..50
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        51..71
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        72..108
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        109..129
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        130..181
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        182..202
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        203..346
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   SITE            74
FT                   /note="Not glycosylated"
FT   CARBOHYD        140
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18585350"
FT   VARIANT         86
FT                   /note="L -> P (in dbSNP:rs2986017)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:18585350, ECO:0000269|PubMed:19070563,
FT                   ECO:0000269|PubMed:19191331, ECO:0000269|PubMed:19191332,
FT                   ECO:0000269|PubMed:19472444, ECO:0000269|PubMed:19545933,
FT                   ECO:0000269|PubMed:19655363, ECO:0000269|PubMed:20061624,
FT                   ECO:0000269|PubMed:20164592, ECO:0000269|PubMed:20847397,
FT                   ECO:0000269|PubMed:21378601"
FT                   /id="VAR_023095"
FT   MUTAGEN         72
FT                   /note="N->G: Significant inhibition on the control of
FT                   cytosolic Ca(2+) levels. Does not affect ion channel
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:18585350,
FT                   ECO:0000269|PubMed:22711817"
FT   MUTAGEN         74
FT                   /note="N->A: Has no effect on glycosylation."
FT                   /evidence="ECO:0000269|PubMed:18585350"
FT   MUTAGEN         114
FT                   /note="W->A: Impairs ability to activate the ERK1 and ERK2
FT                   cascade."
FT                   /evidence="ECO:0000269|PubMed:23345406"
FT   MUTAGEN         121
FT                   /note="D->C: Impaired ion channel activity in response to
FT                   change in extracellular Ca(2+) concentration."
FT                   /evidence="ECO:0000269|PubMed:22711817"
FT   MUTAGEN         121
FT                   /note="D->E: No effect."
FT                   /evidence="ECO:0000269|PubMed:22711817"
FT   MUTAGEN         140
FT                   /note="N->A: Prevents glycosylation and impairs ability to
FT                   activate the ERK1 and ERK2 cascade."
FT                   /evidence="ECO:0000269|PubMed:18585350,
FT                   ECO:0000269|PubMed:23345406"
FT   MUTAGEN         163
FT                   /note="E->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:22711817"
FT   MUTAGEN         166
FT                   /note="D->R: No effect."
FT                   /evidence="ECO:0000269|PubMed:22711817"
FT   CONFLICT        264
FT                   /note="H -> N (in Ref. 2; AAH36193/AAH36208)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   346 AA;  38264 MW;  13A1FBA6592A9EC1 CRC64;
     MMDKFRMIFQ FLQSNQESFM NGICGIMALA SAQMYSAFDF NCPCLPGYNA AYSAGILLAP
     PLVLFLLGLV MNNNVSMLAE EWKRPLGRRA KDPAVLRYMF CSMAQRALIA PVVWVAVTLL
     DGKCFLCAFC TAVPVSALGN GSLAPGLPAP ELARLLARVP CPEIYDGDWL LAREVAVRYL
     RCISQALGWS FVLLTTLLAF VVRSVRPCFT QAAFLKSKYW SHYIDIERKL FDETCTEHAK
     AFAKVCIQQF FEAMNHDLEL GHTHGTLATA PASAAAPTTP DGAEEEREKL RGITDQGTMN
     RLLTSWHKCK PPLRLGQEEP PLMGNGWAGG GPRPPRKEVA TYFSKV
//
